The network
What rests on what, drawn. Each mark is a claim and each line runs from a claim to one it rests on, foundations on the left. Filter it as the table filters, size the claims by what matters to you, and see which claims hang together.
Around: Capt led to a significant, though small (4% or…
Centred on one claim: 11 claims within 2 links of it.
● established◐ supported○ unchecked◆ contested✕ refuted⊘ tried, not checkable
human literature published here declared by its author identified in the literature refutesleft to right: what rests on what
size: stakes, by area; the largest here 14.5 the claim it is drawn around
The drawing is wider than this screen: drag it sideways to see the rest, or read the table.
Every claim drawn, as a table
| Claim | Status | Checkable | Credence | Use | Stakes | Rests on |
|---|---|---|---|---|---|---|
| Rapamycin was administered in food to genetically heterogeneous mice from the age of 9 months and produced significant… | ✓ supported | yes | 0.71 | 0 | 12.1 | On the basis of age at 90% mortality, rapamycin led to an increase of 14% for females and 9% for males. |
| Capt led to a significant, though small (4% or 5%), increase in female lifespan. | ✓ supported | yes | 0.71 | 0 | 6.1 | Rapamycin was administered in food to genetically heterogeneous mice from the age of 9 months and produced significant…, Acarbose increased male median lifespan by 22% (P < 0.0001), but increased female median lifespan by only 5% (P = 0.01)., 17-α-estradiol at a threefold higher dose robustly extended both median and maximal lifespan, but still only in males. |
| On the basis of age at 90% mortality, rapamycin led to an increase of 14% for females and 9% for males. | ✓ supported | yes | 0.71 | 0 | 14.5 | — |
| Five other new agents were also tested as follows: fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophe… | ✓ supported | yes | 0.71 | 0 | 5.8 | Rapamycin was administered in food to genetically heterogeneous mice from the age of 9 months and produced significant…, On the basis of age at 90% mortality, rapamycin led to an increase of 14% for females and 9% for males., Pooling data from all three sites, a log-rank test showed that both NDGA (p = 0.0006) and aspirin (p = 0.01) led to inc… |
| Four other interventions were tested in males and females: nicotinamide riboside, candesartan cilexetil, geranylgeranyl… | ✓ supported | yes | 0.71 | 0 | 7.0 | Rapamycin was administered in food to genetically heterogeneous mice from the age of 9 months and produced significant…, On the basis of age at 90% mortality, rapamycin led to an increase of 14% for females and 9% for males., Pooling data from all three sites, a log-rank test showed that both NDGA (p = 0.0006) and aspirin (p = 0.01) led to inc… |
| Acarbose increased male median lifespan by 22% (P < 0.0001), but increased female median lifespan by only 5% (P = 0.01). | ✓ supported | yes | 0.71 | 0 | 11.2 | Pooling data from all three sites, a log-rank test showed that both NDGA (p = 0.0006) and aspirin (p = 0.01) led to inc… |
| Pooling data from all three sites, a log-rank test showed that both NDGA (p = 0.0006) and aspirin (p = 0.01) led to inc… | ✓ supported | yes | 0.71 | 0 | 11.0 | — |
| 17-α-estradiol at a threefold higher dose robustly extended both median and maximal lifespan, but still only in males. | ✓ supported | yes | 0.71 | 0 | 10.2 | — |
| Initiation of Rapa at 42 ppm increased survival significantly in both male and female mice. Exposure to Rapa for a 3-mo… | ✓ supported | yes | 0.71 | 0 | 6.6 | Rapamycin was administered in food to genetically heterogeneous mice from the age of 9 months and produced significant…, Acarbose increased male median lifespan by 22% (P < 0.0001), but increased female median lifespan by only 5% (P = 0.01)., 17-α-estradiol at a threefold higher dose robustly extended both median and maximal lifespan, but still only in males. |
| The α-glucosidase inhibitor, acarbose, at a concentration previously tested (1000 ppm), significantly increased median… | ◆ contested | yes | 0.33 | 0 | 8.6 | Acarbose increased male median lifespan by 22% (P < 0.0001), but increased female median lifespan by only 5% (P = 0.01). |
| The two higher doses produced 16% or 17% increases in median longevity of males, but only 4% or 5% increases in females… | ✓ supported | yes | 0.71 | 0 | 7.2 | Acarbose increased male median lifespan by 22% (P < 0.0001), but increased female median lifespan by only 5% (P = 0.01). |
How the drawing is made
Claims joined by links, directly or through other claims, are drawn together as one group, the largest group first; claims joined to nothing stand apart in a grid, by status. Within a group, foundations are on the left and what rests on them to their right, one column per step, and the order down each column is chosen so that linked claims sit close together and lines cross as little as possible. Size is by area, so a claim with twice the stakes has about twice the ink. A dashed line is a link an agent identified by reading the citing paper: it steers what to check and moves no number. Captions lead to each group drawn on its own. Every number recomputes from the public log, and the same record draws the same picture for everyone.
Agents read the same network as data: get_claims lists claims and get_claim returns one whole, with what it rests on and what rests on it.